Dongyun Ouyang

Dr. Dongyun Ouyang

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Apoptosis
Verified
Journal Article
Closed access
PDF file
CZCheng-Cheng Zhang
Cheng-Cheng Zhang
CLChen-Guang Li
Chen-Guang Li
YWYao-Feng Wang
Yao-Feng Wang
LXLi-Hui Xu
Li-Hui Xu
XHXian-Hui He
Xian-Hui He
DODongyun Ouyang
Dongyun Ouyang

19 May 2021 in Inflammation
Verified
Journal Article
Closed access
PDF file
MCMing-Ye Chen
Ming-Ye Chen
XYXun-Jia Ye
Xun-Jia Ye
XHXian-Hui He
Xian-Hui He
DODongyun Ouyang
Dongyun Ouyang

1 October 2013 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
DODongyun Ouyang
Dongyun Ouyang
LZLong-Hui Zeng
Long-Hui Zeng
HPHao Pan
Hao Pan
LXLi-Hui Xu
Li-Hui Xu
YWYao Wang
Yao Wang
XHXian-Hui He
Xian-Hui He

9 January 2013 in Autophagy
Verified
Journal Article
Open access
DODongyun Ouyang
Dongyun Ouyang
LXLi-Hui Xu
Li-Hui Xu
XHXian-Hui He
Xian-Hui He
YZYan-Ting Zhang
Yan-Ting Zhang
LZLong-Hui Zeng
Long-Hui Zeng
SRShuai Ren
Shuai Ren
Autophagic responses to chemotherapeutic agents may vary greatly among different prostate cancer cells and have not been well characterized. In this study, we showed that valproic acid (VPA) induce...

2 September 2024 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
YYYi-Ping You
Yi-Ping You
LYLiang Yan
Liang Yan
HKHua-Yu Ke
Hua-Yu Ke
YLYa-Ping Li
Ya-Ping Li
ZSZi-Jian Shi
Zi-Jian Shi
XHXian-Hui He
Xian-Hui He

12 December 2016 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
QZQing-Bing Zha
Qing-Bing Zha
HWHong-Xia Wei
Hong-Xia Wei
CLChen-Guang Li
Chen-Guang Li
YLYi-Dan Liang
Yi-Dan Liang
LXLi-Hui Xu
Li-Hui Xu
DODongyun Ouyang
Dongyun Ouyang
ATP is released by bacteria and host cells during bacterial infection as well as sterile tissue injury, acting as an inducer of inflammasome activation. Previous studies have shown that ATP treatment leads to AMP-activated protein kinase (AMPK) activation. However, it is unclear whether AMPK signaling has been involved in the regulation of ATP-induced inflammasome activation and subsequent pyroptosis. In this study, we aimed to investigate this issue in lipopolysaccharide-activated murine macrophages. Our results showed that AMPK signaling was activated in murine macrophages upon ATP treatment, which was accompanied by inflammasome activation and pyroptosis as evidenced by rapid cell membrane rupture as well as mature interleukin (IL)-1β and active caspase-1p10 release. The ATP-induced inflammasome activation and pyroptosis were markedly suppressed by an AMPK inhibitor compound C or small interfering RNA-mediated knockdown of AMPKα, but could be greatly enhanced by metformin (a well-known AMPK agonist). Importantly, metformin administration increased the mortality of mice with bacterial sepsis, which was likely because metformin treatment enhanced the systemic inflammasome activation as indicated by elevated serum and hepatic IL-1β levels. Collectively, these data indicated that the AMPK signaling positively regulated ATP-induced inflammasome activation and pyroptosis in macrophages, highlighting the possibility of AMPK-targeting therapies for inflammatory diseases involving inflammasome activation.